Benitec Biopharma Releases Q3 2022 Financial Results
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Page 3 - Trial Application News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Trial Application. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Trial Application Today - Breaking & Trending Today
Taysha Gene Therapies Announces Initiation of Clinical Development of TSHA-102 in Rett Syndrome | DNA RNA and Cells
Taysha Gene Therapies Announces Initiation of Clinical Development of TSHA-102 in Rett Syndrome
Source: pipelinereview.com
CASI PHARMACEUTICALS ANNOUNCES FULL-YEAR 2021 FINANCIAL RESULTS AND FOURTH QUARTER 2021 EVOMELA® REVENUE
/PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics...
Source: prnewswire.com
CASI PHARMACEUTICALS : ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL-YEAR 2021 REVENUES AND PROVIDES BUSINESS UPDATES - Form 8-K
CASI PHARMACEUTICALS ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL-YEAR 2021 REVENUES AND PROVIDES BUSINESS UPDATES Expects to Report EVOMELA® Fourth Quarter 2021 Unaudited... | February 16, 2022
Source: marketscreener.com
Immatics and Bristol Myers Squibb Enter Into Global Exclusive License for Immatics' TCR Bispecific Program IMA401
Press release content from Business Wire. The AP news staff was not involved in its creation.
Source: apnews.com